OCULAR THERAPEUTIX, INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Ocular Therapeutix, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2018 to Q3 2024.
  • Ocular Therapeutix, Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 167M shares, a 96.1% increase year-over-year.
  • Ocular Therapeutix, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 85.6M shares, a 3.57% increase from 2022.
  • Ocular Therapeutix, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 82.6M shares, a 0.59% increase from 2021.
  • Ocular Therapeutix, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 82.2M shares, a 35.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 167M +81.9M +96.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 166M +87.8M +112% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 132M +54.6M +70.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 85.6M +2.95M +3.57% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 85.1M +8.17M +10.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 78M -4.49M -5.44% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 77.4M -5.13M -6.22% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 82.6M +482K +0.59% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 77M -8.47M -9.91% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 82.5M +440K +0.54% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 82.5M -4.73M -5.42% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 82.2M +21.4M +35.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 85.4M +16.7M +24.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 82.1M +24.7M +43.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 87.2M +35.3M +68.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 60.8M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 68.8M +16M +30.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 57.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 51.9M +7.73M +17.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q3 2019 52.7M +13.7M +35.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q1 2019 44.2M +9.38M +27% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2018 39M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q1 2018 34.8M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.